WG
ATRS

Winton Group’s Antares Pharma, Inc. ATRS Stock Holding History

Winton Group’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,517
Closed -$46K – 1527
2021
Q3 		$46K Buy
+12,517
New +$50.6K ﹤0.01% 1307
2019
Q2 		– Sell
-28,811
Closed -$87K – 1327
2019
Q1 		$87K Buy
+28,811
New +$93.4K ﹤0.01% 1036

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Winton Group's ATRS Position: Q4 2021 in Review

Winton Group sold out of Antares Pharma, Inc. (ATRS) in Q4 2021, closing a stake of 12,517 shares — an estimated $46K sold.

Winton Group first reported a position in ATRS in Q1 2019 and held it in 2 quarters. The position peaked at $87K in Q1 2019. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

  • Winton Group reported no remaining Antares Pharma, Inc. position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 12,517 Antares Pharma, Inc. shares in Q4 2021, an estimated $46K.
  • Winton Group first reported a position in Antares Pharma, Inc. in Q1 2019 and held it in 2 quarters.
  • Winton Group's Antares Pharma, Inc. position peaked at $87K in Q1 2019.
  • 162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.